source
- Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushBetter-than-expected sales helped Biogen regain the support of investors, while AstraZeneca and GSK worked to convince Wall Street that they can hit ambitious revenue targets.
- Caldera, Vidya add to recent flurry of biotech mergersThe startups are part of a surge of young companies equipped with advanced drug prospects and quickly pivoting to the public markets.BioPharma Dive · 26m ago↗ source